CWM
TECX

C2C Wealth Management’s Tectonic Therapeutic TECX Stock Holding History

C2C Wealth Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-833
Closed -$15.1K – 251
2023
Q2 		$15.1K Hold
833
– – ﹤0.01% 247
2023
Q1 		$9K Buy
+833
New +$11.6K ﹤0.01% 235

Other funds holding TECX

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAM
Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return

C2C Wealth Management's TECX Position: Q3 2023 in Review

C2C Wealth Management sold out of Tectonic Therapeutic (TECX) in Q3 2023, closing a stake of 833 shares — an estimated $15.1K sold.

C2C Wealth Management first reported a position in TECX in Q1 2023 and held it in 2 quarters. The position peaked at $15.1K in Q2 2023. 47 funds tracked by Wall St. Rank hold TECX as of Q3 2023.

  • C2C Wealth Management reported no remaining Tectonic Therapeutic position as of Q3 2023 after selling out during the quarter.
  • C2C Wealth Management sold 833 Tectonic Therapeutic shares in Q3 2023, an estimated $15.1K.
  • C2C Wealth Management first reported a position in Tectonic Therapeutic in Q1 2023 and held it in 2 quarters.
  • C2C Wealth Management's Tectonic Therapeutic position peaked at $15.1K in Q2 2023.
  • 47 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2023.

Based on C2C Wealth Management's 13F filing for Q3 2023, filed 11 Oct 2023.